The duration of pregnancy is influenced by fetal and maternal genetic and non-genetic factors. We conducted a fetal genome-wide association meta-analysis of gestational duration, and early preterm, preterm, and postterm birth in 84,689 infants. One locus on chromosome 2q13 was associated with gestational duration; the association was replicated in 9,291 additional infants (combined P = 3.96 × 10 −14
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Introduction
Pregnancy in eutherian mammals is characterized by tightly regulated physiological processes to ensure normal fetal development and delivery after a narrowly defined period of gestation 1, 2 . A conundrum first posed by Sir Peter Medawar more than 60 years ago is how the semi-allogeneic fetus is protected from attack by the mother's immune system 3 . Compared to many other mammals, humans have a highly invasive placentation process with direct contact with the maternal circulation 1, 4 , and the immunological paradox of pregnancy continues to be an important research topic. It is well-established that successful gestation depends on numerous mechanisms, some of which involve inflammatory pathways 5 . After conception, an inflammatory phase ensures implantation of the blastocyst in the uterine wall 6 . This is followed by a long anti-inflammatory phase in which the maternal adaptive immune response is dampened to allow the development, growth and maturation of the fetus. Eventually, a second inflammatory phase results in gradual ripening of gestational tissues, followed by parturition 6 . Many other pathways are dynamically regulated over the course of a pregnancy and are required for the successful completion of pregnancy and timely parturition 7 .
Correct timing of parturition is critical for the health of the newborn. Preterm birth, defined as birth before 37 completed weeks of gestation, is not only a major cause of perinatal mortality and morbidity 8 , but is also associated with long-term adverse health outcomes including cerebral palsy 9 , diabetes 10 , increased blood pressure 11 , and various psychiatric disorders 12 . Postterm birth, defined as birth after a gestation of 42 completed weeks (hereafter weeks) or more is associated with increased risks of fetal and neonatal mortality and morbidity plus increased maternal morbidity 13 . Each of these outcomes affects approximately 5% to 10% of all births in high income countries 14, 15 and preterm birth rates are considerably higher in some low and middle income countries 16 .
Although timing of parturition is influenced by many non-genetic risk factors, including parity, maternal stress, smoking, urogenital infection, educational attainment and socioeconomic status, there is compelling evidence for a substantial genetic impact 17, 18 . For example, twin and family studies have estimated that the heritability of gestational duration ranges from 25% to 40% 19 . Several studies have shown that the duration of pregnancy has both heritable maternal and fetal components 20, 21 . Estimates from a Swedish family study analysing 244,000 births indicated that fetal genetic factors explained about 10% of the variation in gestational duration, whereas maternal factors accounted for about 20% 21 .
Little is known about specific fetal and maternal genetic contributions to gestational duration. Most genomewide association studies (GWAS) of birth timing have been limited in sample size and have not identified robustly associated genetic loci [22] [23] [24] [25] [26] . Recently, however, a GWAS based on samples from 43,568 women of European ancestry identified maternal genetic variants at six loci associated with gestational duration at P < 5 × 10 −8 with replication in three independent data sets 27 . Three of these loci were also associated with preterm birth as a dichotomous outcome.
In the current study, our goal was to identify fetal genetic variants associated with timing of parturition. We conducted a GWAS meta-analysis of gestational duration as a quantitative trait and early preterm (<34 weeks), preterm (<37 weeks), and postterm (≥42 weeks) birth as dichotomous outcomes, in 84,689 infants from cohorts included in the Early Growth Genetics (EGG) consortium, the Initiative for Integrative Psychiatric Research (iPSYCH), and the Genomic and Proteomic Network for Preterm Birth Research (GPN), with replication analyses in 9,291 infants from additional cohorts. Since a child inherits half of its genetic material from its mother, their genotypes at a given locus are highly correlated, and it may not be clear whether a genetic association reflects the effect of the child's own genotype on the timing of their delivery, or an effect of their mother's genotype on the timing of parturition. For 15,536 of the infants, maternal genetic data were also available, allowing us to address whether identified genetic effects were of fetal or maternal origin.
Results

Discovery stage
Characteristics of the 20 studies included in the discovery stage are presented in Supplementary Table 1 . The discovery data set included information on 84,689 infants, 4,775 of whom were born preterm (<37 weeks), with 1,139 of these considered early preterm infants (<34 weeks). A further 60,148 infants were born ≥39 weeks and <42 weeks of gestation and were used as term controls. Finally, 7,933 infants were born postterm (≥42 weeks). Our study design is illustrated in Supplementary Fig. 1 . After imputation using reference data from the Haplotype Reference Consortium release 1.1 28 or the integrated phase III release of the 1000 Genomes Project
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, each contributing study performed GWAS analyses for at least one of the four study traits, assuming an additive genetic model (see Methods for details). Final meta-analysis results were obtained for >7.5 million SNPs for each of gestational duration, early preterm birth, preterm birth, and postterm birth, with genomic inflation factors <1.05. Quantile-quantile and Manhattan plots for the four phenotypes are shown in Supplementary Fig. 2 . In the discovery GWAS meta-analysis, one locus (on chromosome 2q13) was associated with gestational duration and postterm birth at genome-wide significance (P < 5 × 10 −8 ) (Supplementary Fig. 2A and 2B), and two loci (on chromosomes 1p33 and 3q28) were significantly associated with early preterm birth (Supplementary Fig. 2C ). No locus reached genome-wide significance for preterm birth (Supplementary Fig.  2D ). We selected one lead SNP for each of the three loci reaching genome-wide significance for analysis in the replication stage.
A locus harboring pro-inflammatory cytokine genes
At the 2q13 locus, rs7594852 was the SNP most significantly associated with gestational duration (P = 1.88 × 10 −12 , Figure 1A ) and was selected as the lead SNP for replication stage analysis. For postterm birth, we also selected rs7594852 (P = 4.64 × 10 −8 , Figure 1B) as the lead SNP for the replication analyses from a set of highly correlated SNPs (r 2 > 0.98) with very similar P values. The association of rs7594852 with gestational duration was replicated, with a P value of 3.69 × 10 −3 in the replication sample and an overall P value of 3.96 × 10 −14 in the combined discovery and replication analysis ( Table 1 ). In the combined analysis, each additional fetal rs7594852-C allele was associated with an additional 0.37 days (95% confidence interval (CI) = 0.22−0.51) of gestational duration. For postterm birth the statistical power to replicate the association was modest at 40% (Supplementary Table 2 ) and the SNP did not reach nominal significance in the replication stage analysis, although the direction of the effect was consistent with the discovery stage ( Table 1) . rs7594852 is intronic in CKAP2L and is located in a linkage disequilibrium (LD) block that encompasses IL1A, IL1B, and several other genes encoding proteins in the interleukin 1 cytokine family (Figures 1A and 1B) . In an additional analysis conditioning on rs7594852, we found no evidence for multiple independent signals at the locus (Supplementary Fig. 3 ). Figure 2 shows a forest plot of association results for rs7594852 across all studies. The estimated variance in gestational duration explained by rs7594852 was 0.066%. The variance explained by all common SNPs (minor allele frequency, MAF>1%) was 7.3% (SE=0.7%).
No association was seen at the 2q13 locus in case-control analyses of early preterm birth or preterm birth ( Supplementary Fig. 4) , suggesting that the locus primarily influences gestational duration in the later stages of pregnancy. To further investigate this question, we binned the 51,357 births from the largest contributing study (iPSYCH) in 10 groups of equal size by gestational duration. We then estimated the frequency of the rs7594852-C allele in each group and in the whole sample. In the overall meta-analysis, each additional fetal rs7594852-C allele was associated with increased gestational duration ( Table 1 ). The frequencies of the rs7594852-C allele in the two groups with shortest gestational durations were only slightly lower than the frequency in the whole sample (Supplementary Fig. 5 ). The lowest allele frequency (0.514) was seen in the third group, representing a mean gestational duration of 276 days. The allele frequency then gradually increased in the next groups with the highest frequency (0.551) observed for the group representing the longest gestational duration (mean of 296 days) (Supplementary Fig. 5 ).
To explore possible functional mechanisms underlying the association signal at the 2q13 locus, we annotated the 283 variants within 1Mb of the lead SNP that were associated with gestational duration with P < 1 × 10 −4 (Supplementary Table 3 ) and decreased expression of IL1B in lymphoblastoid cell lines (P = 4.41 × 10 −6 ). Among the 283 top variants at the 2q13 locus, 104 are located in likely enhancer regions of (mainly) cytokine genes (see Methods). GWAS Catalog 32 annotation revealed that the variant rs10167914 (P = 2.66 × 10 −7 for gestational duration, r 2 = 0.64 with rs7594852) has been reported to be associated with endometriosis 33 (P < 5 × 10 −8 ), with the risk allele for endometriosis corresponding to increased gestational duration in our data (Supplementary Table 3 ).
Exome sequencing data were available for 11,455 subjects from the iPSYCH study. To investigate whether exonic variants could explain the observed association at the 2q13 locus, we tested all exonic variants in a 1 MB region around the lead SNP rs7594852 for association with gestational duration (see Methods). Among 841 exonic variants tested, 14 were associated with gestational duration at P < 0.01, with the lowest P = 0.0005. These variants were, however, either not in LD with rs7594852 (r 2 <0.01) or did not remain associated after conditioning on rs7594852 genotype (Supplementary Table 5 ). Thus, we found no exonic variants likely to explain the observed association.
Early preterm birth associations
Our early preterm birth meta-analysis revealed two genome-wide significant loci in the discovery stage. At the first locus on chromosome 3q28, rs112912841 yielded the lowest P value (OR = 1.64, 95% CI = 1.38−1.94, P = 9.85 × 10 −9 ). This SNP is intronic in LPP (Supplementary Fig. 6A ). The most significant SNP at the second locus on chromosome 1p33, rs1877720 (OR = 1.64, 95% CI = 1.37−1.96, P = 4.33 × 10
), is intronic in SPATA6 (Supplementary Fig. 6B ). There was no evidence for multiple independent signals at these loci when the lead SNP was included as a co-variate in conditional regression analyses (Supplementary Fig. 7 ). We conducted replication analyses for the two lead SNPs (rs112912841 and rs1877720) in an independent Finnish casecontrol study (107 infants born early preterm and 865 born at term), but statistical power was low (Supplementary Table 2 ) and we could not confirm the associations ( Supplementary Fig. 8 and Supplementary Table 6 ). We also conducted family-based association tests of the lead SNPs at these two loci in a set of 276 early preterm birth trios of European ancestry from Iowa, but could not find support for the signals in that data set either (Supplementary Table 7 ).
Fetal or maternal genetic effects?
Gestational duration is a complex outcome influenced by both the maternal and fetal genomes. To disentangle fetal and maternal genetic effects, we first compared our fetal association results with those from a recent maternal GWAS of gestational duration 27 . In our fetal analysis, each C allele of the lead variant, rs7594852, was associated with an additional 0.37 days (95% CI = 0.22−0.51) of gestational duration (estimate based on 51,357 infants from the iPSYCH study, see Methods). In the published maternal GWAS (n = 43,568), the direction of effect was the same: each maternal rs7594852-C allele was associated with an additional 0.22 days (95% CI = -0.01−0.45) of gestational duration, though the confidence intervals were wide and included the null value. The fact that the maternal effect estimate was approximately half the size of the fetal effect estimate (0.22 vs. 0.37 days) is as expected if the association is of fetal origin. Next, we performed joint maternal-fetal genetic association analyses of the lead variant, rs7594852, at the 2q13 locus in 15,536 mother-child pairs that met the inclusion criteria from the discovery stage (see Methods for details). Here we found that conditioning on maternal genotype did not attenuate the fetal genetic association while the maternal genetic association conditional on fetal genotype was non-significant (Supplementary Table 8 ). Taken together, these results indicate that the association signal for gestational duration at the 2q13 locus represents a fetal genetic effect. Conversely, we examined the lead variants at 4 of the 6 loci, which were reported to be significant in the maternal GWAS and were available in our meta-analysis (the remaining 2 were not autosomal) 27 . The direction of effects in the fetal GWAS was consistent with the published maternal GWAS results, but fetal effect size estimates were smaller (Supplementary Table 9 ).
Functional analyses
Exome sequencing data and variant annotation of the 2q13 locus did not identify any exonic variants likely to explain the association with gestational duration, suggesting that the underlying mechanism might instead involve altered gene regulatory mechanisms. To investigate potential mechanisms, we conducted a series of functional experiments and analyses. We first prioritized all SNPs in the LD block containing the association signal based on their overlap with functional genomics datasets from cell types relevant to gestation (see Methods). The highest ranked variant was the discovery lead variant rs7594852, which overlaps with 17 different datasets, with no other variant intersecting more than three (Supplementary Table 10 ). We then used the Cis-BP database 34 to identify transcription factors that might bind differentially to this variant. These analyses revealed that the rs7594852-C allele might alter the binding of the hypermethylated in cancer 1 (HIC1) protein ( Figure 3A) . The HIC1 protein is a C2H2 zinc finger transcriptional repressor with a consensus DNA binding sequence containing a core "GGCA" motif 35 . Protein binding microarray enrichment scores (E-scores) indicate strong binding of HIC1 to the cytosine "C" allele (E-score = 0.48), and only moderate binding to the alternative thymidine ("T") allele (E-score = 0.32). We confirmed the presence of multiple histone marks overlapping rs7494852 in various fetal cell and tissue types (chorion, amniocytes, trophoblasts) 36 , indicating that the chromatin in this locus is likely accessible and active in these fetal cells ( Figure 3B ). In particular, the fetal side of the placenta displays a strong H3K4me3 modification signal, a histone mark often found in active regulatory regions. Using an electrophoretic mobility shift assay, we detected enhanced binding of HIC1 to the rs7594852-C allele (Figure 3C) , as predicted. Densitometric analysis for HIC1 band intensity demonstrated a statistically significant difference in average intensity between the rs7594852-C and rs7594852-T alleles respectively (204.0±60.0 vs 76.6±42.3, P = 0.013; n = 4 per group). Additional experiments are needed to investigate which of the genes at the 2q13 locus have altered transcriptional levels in relevant cell types due to the enhanced binding of HIC1 to the rs7594852-C allele.
Next, we examined associations of the lead SNP, rs7594852 with gene expression using RNA sequencing data from 102 human placentas 37 . Here we found that among 118 genes/transcripts with transcription start sites within 500 kb of rs7594852, there were five nominally significant (P < 0.05) cis-eQTL associations (Supplementary Table 11 ). Three of these genes (IL1A, IL36G, IL36RN ) encode proteins in the interleukin 1 cytokine family. The rs7594852-C allele, which in our data was associated with increased gestational duration, corresponded to decreased expression of the cytokine-encoding genes IL1A and IL36G. Conversely, the rs7594852-C allele corresponded to increased expression of IL36RN, which encodes an antagonist to the interleukin-36-receptor. Finally, to evaluate a possible general effect of the 2q13 locus on inflammatory markers we tested for associations between the lead SNP rs7594852 and levels of inflammatory markers in peripheral blood from newborns, using data from the iPSYCH study. None of the cytokines encoded by genes at the 2q13 locus had been assayed, but measurements of the biomarkers BDNF, CRP, EPO, IgA, IL8, IL-18, MCP1, S100B, TARC, and VEGFA were available for 8,138 iPSYCH samples. However, we found no significant associations between rs7594852 genotype and levels of these biomarkers (results not shown). We also used the GWAS Catalog 32 to identify 39 SNPs known from previous studies to be associated with cytokine levels and examined associations for these SNPs with gestational duration in our discovery stage meta-analysis. These SNPs did not show more evidence of association with gestational duration than expected by chance (Supplementary Fig. 9 ).
Discussion
In this genome-wide meta-analysis including a total of 93,980 infants in the discovery and replication stages, we identified a fetal locus on chromosome 2q13 that was robustly associated with gestational duration. The lead SNP at the locus, rs7594852, was also associated with postterm birth as a dichotomous outcome in the discovery stage, but not with either preterm birth or early preterm birth. An analysis of allele frequency in different strata of the gestational age distribution confirmed that genetic variation at the locus influences timing of parturition in later stages of pregnancy.
Gestational duration is a complex phenotype influenced by both fetal and maternal genetic contributions, as well as environmental factors. Since mothers and children share half of their genetic material, we investigated the possibility that the 2q13 association signal could represent a maternal, rather than a fetal, effect. This was not the case: our analysis of more than 15,000 mother-child pairs showed that the association had a fetal origin independent of the maternal genotype. Furthermore, the lead SNP, rs7594852, was not significantly associated with gestational duration in a maternal GWAS including more than 40,000 women 27 . More generally, we found that fetal genetic variants explained 7.3% of the variance in gestational duration, which is broadly in line with estimates of 11% and 13.1% from large family studies in populations of Scandinavian origin 20, 21 .
While the lead SNP at the new 2q13 locus is intronic in CKAP2L, which encodes a mitotic spindle protein, the locus also harbors a number of genes encoding proteins in the interleukin 1 family of pro-inflammatory cytokines. It is well-established that IL-1 signalling plays a central role in the process leading to parturition in healthy term pregnancies 38 . However, infections or trauma can also induce increased secretion of IL-1 and other pro-inflammatory cytokines, provoking preterm birth 38 . In our data, genetic variation at the 2q13 locus was only associated with gestational duration in later stages of pregnancy. We hypothesize that this locus is involved in genetic regulation of a pro-inflammatory cytokine signalling mechanism by which the mature fetus communicates to the mother that it is ready to be born. In a first step towards understanding the molecular mechanisms underlying the genetic association, we found that the rs7594852-C allele creates a strong binding site for the transcriptional repressor HIC1. It is conceivable that the variant thereby delays signalling from the fetus to the mother, thus prolonging gestation, possibly until other (redundant) mechanisms stimulating parturition take effect. We had limited statistical power to directly evaluate effects of the variant allele on expression levels of genes at the locus, but the results of eQTL analyses in 102 placental samples collected after birth were compatible with the hypothesis that the rs7594852-C allele may lead to prolonged gestational duration through decreased gene expression of one or more members of the interleukin 1 cytokine family genes. eQTL results from the GTEx and GEUVADIS data bases for skin tissue and lymphoblastoid cell lines, respectively, support this suggestion. However, to fully investigate this hypothesis, larger sample sizes and further functional follow-up experiments are needed, including fine-mapping of the locus and characterization of pro-inflammatory cytokine signalling shortly before parturition e.g., through non-invasive techniques allowing quantification of cell-free fetal RNA 39, 40 and measurement of cytokine levels.
The fact that the 2q13 locus was not associated with preterm birth or early preterm birth in our case-control analyses underlines that genetic triggers of parturition probably change as gestation advances. Genetic analysis of preterm birth is further complicated by the possible influence of a wide range of environmental factors. Population-based heritability analyses of gestational duration demonstrate that inclusion of early preterm births results in decreased estimates of the fetal genetic effect 20 and previous GWAS efforts have not identified robust fetal genetic associations with preterm birth [22] [23] [24] . To refine outcome definitions, we applied a range of exclusion criteria, but although our analyses were based on almost 5,000 infants born preterm, with 1,139 of these considered early preterm births, no loci were robustly associated with preterm birth. Statistical power calculations suggested that our preterm birth analyses were well-powered to detect associations with common (MAF>0.1) fetal genetic variants with odds ratios >1.25 (Supplementary Fig. 10 ). Fetal genetic contributions to preterm birth may therefore involve smaller effect sizes or less frequent variants. Studies with larger sample sizes would be needed to address this question.
Our study had some limitations, including the restriction to infants of European descent. Further studies are therefore warranted to delineate fetal and maternal genetic contributions to gestational duration in populations of non-European ancestries. A second limitation of our study was the differences in gestational duration ascertainment from study to study. In many of the older cohorts that recruited women who were pregnant prior to routine use of ultrasound scan dating, gestational duration estimates were based largely on maternal-reported last menstrual period at the time of pregnancy, whereas estimates for infants born more recently were predominantly based on first-trimester ultrasound screening (Supplementary Table 1) . Also, the degree to which children were excluded based on maternal conditions or pregnancy complications differed among cohorts. However, while these sources of heterogeneity may have caused some underestimation of effect sizes at genuinely associated loci, it should not have resulted in increased false-positive rates. Our extensive exclusion criteria aimed to focus on 'natural' gestational duration rather than specific causes such as preterm birth due to pregnancy complications, assisted delivery or congenital anomalies. Although such exclusions can result in selection bias 41 , the overall consistency between studies (Table 1, Figure 2) , despite their varying ability to completely apply all of our pre-specified exclusion criteria, provides some reassurance that any such bias may not be large. One might also speculate as to whether spurious signals could arise from the case groups of various diseases that were included in the discovery stage analyses. However, we consider this unlikely since the association analyses were stratified by disease group and since we did not observe heterogeneity of effect estimates between studies of various design (including population-based cohorts) for the 2q13 lead variant (Table 1, Figure 2 ).
In conclusion, parturition is a complex physiological process involving multiple redundant mechanisms influenced by maternal and fetal factors 2 . An enhanced understanding of these mechanisms is of great public health importance, since giving birth either before or after the window of term gestation is associated with increased morbidity and mortality 8, 13 . Our study identified the first robustly associated fetal genetic locus for gestational duration. The effect was observed in later stages of pregnancy and our results raise the hypothesis that variants at the associated locus influence the regulation of pro-inflammatory cytokines in the IL-1 family. Our findings provide a foundation for further functional studies that are required to refine our understanding of the biology of the timing of parturition. 0.58 * For the quantitative trait of quantile transformed gestational duration, the column reports beta estimates. For the dichotomous trait postterm birth, odds ratio (OR) estimates are given; CI, confidence interval; I 2 , heterogeneity estimate (proportion of variance that is due to between study differences); Phet, P value from the Cochran Q test of between study heterogeneity.
URLs
Methods
Discovery stage cohorts
Analyses were performed among participants of studies in the Early Growth Genetics (EGG) consortium, the Initiative for Integrative Psychiatric Research (iPSYCH), and the Genomic and Proteomic Network for Preterm Birth Research (GPN). The iPSYCH sample (n = 51,357) included patient groups of six mental disorders: autism, ADHD, schizophrenia, bipolar disorder, depression and anorexia 42 . Participating studies from the EGG consortium included the Avon Longitudinal Study of Parents and Children (ALSPAC, n = 6,072) study, the Children's Hospital of Philadelphia (CHOP, n = 1,445) cohort, three sub-samples from the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC_REGISTRY, n = 933; COPSAC2000, n = 356; COPSAC2010, n = 618), a sub-sample from the Danish National Birth Cohort (DNBC, n = 2,130), the Exeter Family Study of Children's Health (EFSOCH, n = 699) study, the GENERATION R (GenR, n = 1,331) study, the Hyperglycemia and Adverse Pregnancy Outcome (HAPO, n = 1,347) study, the Infancia y Medio Ambiente (INMA, n = 994) study, a sub-sample of the Norwegian Mother and Child cohort study (MoBa_2008, n = 1064), two Northern Finland Birth Cohort studies (NFBC1966, n = 5,209, and NFBC1986, n = 2,494), the Western Australian Pregnancy Cohort Study (Raine Study, n = 334), a sub-sample of Statens Serum Institut's genetic epidemiology (SSI-GE, n = 3,294) studies, the Special Turku coronary Risk factor Intervention Project (STRIP, n = 441), the Diabetes and Inflammation Laboratory (1958BC (DIL-T1DGC), n = 2,168) cohort, and the Wellcome Trust Case Control Consortium 1958 British Birth Cohort (1958BC (WTCCC), n = 2,403). Study protocols within the EGG consortium were approved at each study centre by the local ethics committee and written informed consent had been obtained from all participants and/or their parent(s) or legal guardians. Regarding the iPSYCH and SSI-GE cohorts, parents are informed in writing about the neonatal screening and that the samples can be used for research, pending approval from relevant authorities 42 . The GPN study genotype and phenotype data were downloaded from dbGaP (https://www.ncbi.nlm.nih.gov/gap, accession number: phs000714.v1.p1) and 190 early preterm cases and 274 term infants were included in our early preterm and preterm birth meta-analysis. Study descriptions, relevant sample sizes and basic characteristics of samples in the discovery stage are presented in Supplementary Table 1 .
Replication stage cohorts
Three population based cohorts were used for replication stage analyses of the lead SNPs for gestational duration and early preterm birth, namely an additional sub-sample of the Norwegian Mother and Child cohort study (MoBa_HARVEST, n = 7,072), the Born in Bradford study (BiB, n = 1,354), and a Finnish cohort from Helsinki (FIN, n = 865). We also included a set of mother-father-child trios from Iowa (n = 276 trios) for familybased association testing of the lead SNPs for early preterm birth. The study characteristics of these four studies are described in Supplementary Table 1.
Exclusion criteria for cases and controls
We excluded pregnancies based on the following criteria: 1) stillbirths; 2) twins or any multiple births; 3) ancestry outliers using principal component analysis; 4) outliers in birth weight or birth length (gestational duration possibly wrong); 5) Caesarian section, if due to pregnancy complications; Caesarian sections due to complications during labor were not excluded. Caesarian sections were allowed for cases in the postterm birth analysis; 6) Physician initiated births (induced births were allowed for cases in the postterm birth analysis); 7) placental abruption, placenta previa, pre-eclampsia/eclampsia, hydramnios, placental insufficiency, cervical insufficiency, isoimmunization, gestational diabetes, cervical cerclage; 8) pre-existing medical conditions in the mother, such as diabetes, hypertension, autoimmune diseases (including systemic lupus erythematosus, rheumatoid arthritis and sclerodermia), immuno-compromised patients; and 9) known congenital anomalies. Further, the study sample was restricted to individuals of European ancestry, in most cohorts by principal component analysis. Some cohorts were not able to perform exclusions according to all criteria, but applied as many criteria as possible (see Supplementary Table 1 for details).
Data cleaning and imputation
Genotyping in each of the contributing studies was conducted using various high-density SNP arrays (see Supplementary Table 1 for details). Data cleaning was done locally for each study, with sample level exclusion criteria based on high genotype missing rate, high autosomal heterozygosity rate, discrepancy between reported sex and the sex inferred from genotyping, and sample heterogeneity, as well as SNP-level exclusion criteria based on call rate, Hardy-Weinberg disequilibrium, duplicate discordance, Mendelian inconsistencies, and low minor allele frequency. Imputation was performed based on reference data from the Haplotype Reference Consortium (HRC) release 1.1 28 for most studies. The iPSYCH sample was imputed based on the integrated phase III release of the 1000 Genomes Project 29 . Study-specific details on data cleaning filters and imputation are given in Supplementary Table 1. SNP positions were based on National Center for Biotechnology Information (NCBI) build 37 (hg19) and alleles were labelled on the positive strand of the reference genome.
GWAS analysis
We analysed four traits for association with fetal genotypes, including three binary case-control traits (early preterm birth, preterm birth, and postterm birth) and one quantitative trait (gestational duration). Early preterm birth cases were defined as infants born before gestational week 34+0 (i.e. <238 days of gestation); preterm birth cases were infants born before gestational week 37+0 (i.e. <259 days of gestation, including the early cases); postterm birth cases were infants born at or after gestational week 42+0 (i.e. ≥ 294 days of gestation). The controls used in the analyses of these three traits were defined as infants born at or after gestational week 39+0 and before gestational week 42+0 (i.e. ≥ 273 days of gestation, and < 294 days of gestation). Case groups in each study contributing to the discovery stage analyses were required to contain at least 50 individuals.
For the dichotomous traits early preterm birth, preterm birth, and postterm birth, the genome-wide association analyses within discovery studies was done by logistic regression using imputed allelic dosage data under an additive genetic model. For the quantitative trait gestational duration, we applied a rank-based inverse normal transformation. More specifically, in each cohort gestational duration in days (in some cohorts converted from weeks; see Supplementary Table 1 ) was regressed on infant sex and the resulting residuals were quantile transformed to a standard normal distribution before being tested for association with fetal SNP genotypes. The DNBC and MoBa_2008 samples represent case-control studies of preterm birth, which means that the distribution of gestational duration is bimodal for these studies. In these two cohorts, we transformed gestational duration to be on the same scale as the population-based cohorts (See Supplementary Methods and Supplementary Fig. 11 for details) .
Some of the analyzed cohorts represent case-control studies of various diseases. For these, the association analyses of the four outcomes of interest were done in strata defined by disease group. Thus, the iPSYCH study was divided into six patient groups (autism (n = 7,147), ADHD (n = 8,606), schizophrenia (n = 1,101), bipolar disorder (n = 864), depression (n =13,836), and anorexia (n = 1,924)) and a population control group (n = 17,879), which were analyzed separately and combined by fixed-effects meta-analysis. Similarly, the SSI-GE sample was split into six patient groups (atrial septal defects (n = 368), febrile seizures (n = 1,350), hydrocephalus (n = 289), hypospadias (n = 301), opioid dependence (n = 685), and postpartum depression (n = 301)) (see Supplementary Table 1 for details), which were analyzed separately and combined by fixed-effects meta-analysis. Genome-wide association analyses in each cohort/sub-sample was conducted using PLINK 43 , SNPTEST 44 or RVTESTS 45 .
We obtained effect size estimates of the lead variant for gestational duration in the unit of days based on the iPSYCH study. Using a linear model, we regressed gestational duration in days on SNP allele dosage within each iPSYCH disease group, adjusting for infant sex. A combined estimate was obtained by fixed-effects inversevariance meta-analysis. The iPSYCH study was also used to obtain frequency estimates for the lead variant for gestational duration within samples grouped by gestational duration. In this case, iPSYCH disease status was omitted from the model, since sample sizes would be too small if analyses were stratified by gestational duration groups as well as iPSYCH disease groups.
Meta-analysis
Prior to meta-analysis, SNPs with a minor allele frequency (MAF) <0.01 and poorly imputed SNPs (r2hat <0.3 from MACH 46 or info <0.4 from SNPTEST 44 ) were excluded. Furthermore, SNPs available in less than 50% of the discovery cohorts for each trait were excluded. To adjust for inflation in test statistics generated in each cohort, genomic control 47 was applied once to each individual study (see Supplementary Table 12 for λ values in each study). The sub-samples within iPSYCH and SSI-GE were meta-analyzed separately first and estimates were then adjusted by genomic control again. Finally, we combined results from all discovery cohorts using fixedeffects inverse variance-weighted meta-analysis as implemented in METAL 48 . Final meta-analysis results were obtained for 7,646,297 SNPs for gestational duration with a genomic inflation factor (λ) of 1.049, 7,588,467 SNPs for early preterm birth (λ=1.005), 7,545,601 SNPs for preterm birth (λ=1.013), and 7,583,965 SNPs for postterm birth (λ=1.026). Heterogeneity between studies was estimated using the I 2 statistic 49 . Combined analysis of the discovery and replication stage data was also conducted by fixed-effects inverse varianceweighted meta-analysis. We considered SNPs with P < 0.05 in the replication stage and P < 5 × 10 −8 in the combined analysis to indicate robust evidence of association.
Power analysis
We assessed the statistical power of our study design by computer simulations in R 50 . For gestational duration, we simulated a quantitative trait influenced by an additive genetic effect and allowed the effect size and the effect allele frequency to vary. For early preterm, preterm, and postterm birth, we simulated disease state from a logistic regression model allowing the odds ratio for a log-additive genetic effect and the frequency of the effect allele to vary. For each combination of effect size and effect allele frequency, we simulated 5000 data sets using the relevant sample size (e.g., for preterm birth: 4,775 cases and 60,148 controls in the discovery stage). We then conducted association tests on the simulated data sets and calculated power as the proportion of tests with a P value lower than the relevant significance level (P < 5 × 10 −8 for the discovery stage and P < 0.05 for the replication stage).
Bioinformatics analysis
To investigate the functional characteristics of our findings, we annotated all variants with P < 1 × 10 −4 at the 2q13 locus using ANNOVAR 51 (accessed 1 June, 2017), a tool that retrieves variant and region-specific functional annotations from several databases. We retrieved eQTL information for these variants from the GTEx V6 30 , and GEUVADIS 31 project databases. We also queried GeneHancer
52
, a database of human enhancers and their inferred target genes, which has integrated four different enhancer datasets, including the Encyclopedia of DNA Elements (ENCODE), the Ensembl regulatory build, the functional annotation of the mammalian genome (FANTOM) project and the VISTA Enhancer Browser. Gene-enhancer scores (>5) were included in the annotation of the variants. We further downloaded all reported variants in the National Human Genome Research (NHGRI) GWAS Catalog 32 (accessed 24 Nov, 2017) associated with a trait or disease at P < 5 × 10 To assess possible enrichment of cytokine-related variants in the association results for gestational duration, we did a quantile-quantile plot of observed versus expected -log10 P values of SNPs known to be associated with cytokine levels (Supplementary Fig. 9 ). The cytokine related SNPs were restricted to cytokine GWAS publications [54] [55] [56] , in which the association had been reported in the GWAS Catalog with P < 5 × 10 −8 .
Exome analysis
Exome sequencing data were available for a subset of samples in the iPSYCH study and analysis was restricted to the overlap between iPSYCH exome samples and the part of the iPSYCH cohort that were included in the GWAS. In total, n = 11,455 individuals, sampled from either schizophrenia (n = 1,036), bipolar (n = 816), ADHD (n = 2,353), autism (n = 2,664), affective disorder (n = 1) or controls (n = 4,585) were analyzed. For these samples, variants within a 1 MB region (113MB -114MB) containing the 2q13 association signal were extracted and combined with the genotype data for the lead variant rs7594852. For these variants, association analysis was performed with gestational duration, transformed as described above. We adjusted the regression model for sex and the first three principal components obtained from the genotyping data. Due to small sample size in the strata of inclusion diagnosis, we did not perform analyses within strata of inclusion diagnosis but instead performed adjustment for four indicator variables denoting whether the individual has schizophrenia, ADHD, bipolar disorder or autism. In addition, association analysis conditioned on rs7594852 was performed by adding rs7594852 dosage as a covariate.
Biomarker analysis
Measurement of the biomarkers BDNF, CRP, EPO, IgA, IL8, IL-18, MCP1, S100B, TARC, and VEGFA was conducted based on infant dried blood spot samples obtained a few days after birth during routine neonatal screening. We tested each measured analyte for association with the lead SNP rs7594852 for gestational duration. We first fitted a linear model with age as a predictor and then normalized and log-transformed the residuals. The log-transformed residuals were tested for association with rs7594852 dosage while adjusting for infant sex, 6 principal components and iPSYCH disorders.
eQTL analysis in placental samples
eQTL analyses were conducted based on existing RNA sequencing data in placental samples from the Rhode Island Child Health Study. Placenta tissues were from singleton, term pregnancies without pregnancy complications. Details on sample collection, DNA and RNA extraction, SNP array genotyping and RNA sequencing have been described previously 37 . In the eQTL analyses of the current study, the sample was restricted to 102 infants of European ancestry. Only genes/transcripts with transcription start sites within 500 kb of the lead SNP rs7594852 for gestational duration, with a total read count > 50 across all samples, and with >1 counts per million (cpm) in at least two samples, were considered.
Computational prediction of gene regulatory mechanisms
In order to prioritize genetic variants for experimental validation, we ranked all variants at the 2q13 locus with r 2 >0.8 to the lead SNP, rs7594852, by their likelihood of being functional based on the strength of the supporting functional genomic data (e.g., ChIP-seq peaks for transcription factors or histone marks, open chromatin as measured by DNAse-seq, see Supplementary Table 10 for details). We used a wide range of functional genomic data in our analysis obtained from sources such as the UCSC Genome Browser . By restricting our analysis to studies performed in relevant cell lines (placenta, chorion, amnion, trophoblasts, neutrophils, and macrophages), we prioritized those variants likely to have regulatory function in these cells. Variants were ranked based upon the total number of datasets they overlap, which is a similar strategic scheme to that employed by RegulomeDB 61 .
Electrophoretic mobility shift assays (EMSAs)
EMSAs were performed to determine whether the rs7594852 polymorphism at the 2q13 locus differentially affected HIC1 binding. Recombinant human HIC1 purified protein (ORIGENE #TP322752) was obtained from ORIGENE (expressed in HEK293 using TrueORF clone, RC222752) with a c-Myc/DDK tag. Double-stranded IRDye700 5' end-labelled 39 bp oligonucleotides, identical except for the nucleotide at rs7594852 (either the "C" or "T" allele), were obtained from IDT. The oligo sequence of the common "C" allele is:
5' -IRDye700/ GCCAGACCCCGCCTCCTGGCACAGAGGACCACGCCCGGC-3'.
The alternative "T" allele oligo sequence is:
5' -IRDye700/ GCCAGACCCCGCCTCCTGGTACAGAGGACCACGCCCGGC -3'.
The DNA binding reaction buffer contained 1x binding buffer, 1x DTT/Tw20, 1μg poly(dI-dC), 0.05% NP-40 (LI-COR EMSA buffer kit), and 1mM zinc acetate. Binding reactions contained 435 ng of purified HIC1 protein. 50fmol fluorescent oligo DNAs were then added to the appropriate protein/binding mix and incubated for 20 min at room temperature. For supershift assays, 1 ug per lane of mouse anti-DDK (FLAG) monoclonal antibody (ORIGENE #TA50011-100) was incubated with the binding buffer for 20 min prior to addition of and incubation with oligo DNA. 1x orange loading dye (LI-COR kit) was added to samples, which were then resolved on (precast, pre-run at 100V for 60min) 6% TBE gels (Novex,13 ThermoFisher) in 0.5x TBE buffer for 120 min at 80V (4C). Fluorescent bands were then imaged using a LI-COR chemiluminescent imaging system. EMSA experiments display representative panels of 2-3 replicates. Densitometric analysis for HIC1 band intensity was performed using a Licor Odyssey scanner.
Estimating fetal and maternal genetic effects
For the 2q13 locus, we analyzed up to 15,536 mother-child pairs from seven studies with both fetal and maternal genotypes available (ALSPAC, BiB, DNBC, EFSOCH, FIN, MoBa_2008, and MoBa_HARVEST). We used linear regression to test the association between quantile transformed gestational duration (same transformation as in the main analysis) and fetal genotype conditional on maternal genotype and vice versa. In the same complete mother-child pairs (i.e. where genotype data were available for both mother and child), we estimated unconditional effects of fetal and maternal genotype, respectively. We combined the results from the individual studies using fixed-effects meta-analysis.
Fraction of variance explained
To estimate the fraction of variance in gestational duration explained by the lead variant rs7594852 at the 2q13 locus we fitted a linear regression model of quantile transformed gestational duration in the iPSYCH cohort (n = 51,357) where the variant was genome-wide significant. The model was corrected for iPSYCH disease group and the fraction of variance explained by rs7594852 genotype dosage was extracted. The estimate of variance explained by all common autosomal SNPs (MAF > 1%) was calculated based on the discovery stage meta-analysis results using LD Score regression 62 .
